EW

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Edwards Lifesciences Corp

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
CEO
Michael Mussallem
Employees
14900
Headquarters

1 Edwards Way
Irvine, California 92614-5688
Phone: 19492502500
www.edwards.com

News

Project Overmatch’s Small says EW is ‘killer app’ for unmanned tech
Apr 11, 2024 15:34pm

… initiative. The project leans on tech in other domains, such as …


Source:EIN News Tech
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
Apr 07, 2024 20:30pm

Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families. The findings of this study, which identified a significant discrepancy between participant self-awareness and actual prevalence of heart disease and Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Edwards Lifesciences executive sells over $2.7 million in stock
Apr 04, 2024 22:28pm

https://www.investing.com/news/company-news/edwards-lifesciences-executive-sells-over-27-million-in-stock-93CH-3366729


Source:Investing.com
Edwards Lifesciences CFO sells shares worth over $688k
Apr 01, 2024 23:00pm

https://www.investing.com/news/company-news/edwards-lifesciences-cfo-sells-shares-worth-over-688k-93CH-3360710


Source:Investing.com
Edwards Lifesciences Announces Upcoming Board Chair Transition
Mar 26, 2024 20:24pm

Edwards Lifesciences (EW) has shared an announcement. Michael A. Mussallem is set to retire as Non-Executive Chairman and director of Edwards Lifes…


Source:TipRanks
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Mar 19, 2024 18:24pm

Edwards Lifesciences sees its Relative Strength Rating hit the 80-plus level.


Source:Investor''s Business Daily
Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook By Investing.com
Mar 18, 2024 10:15am

© Reuters. On Monday, Edwards Lifesciences (NYSE:), a prominent player in the medical technology industry, saw its share price target increased from $93.00 to $100.00 by Oppenheimer, while the firm maintained its Outperform rating on the stock. The revision reflects the analyst’s view on the potential of transcatheter tricuspid valve therapies, a growing area of […] The post Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook By Investing.com appeared first on TheAdviserMagazine.com .


Source:TheAdviserMagazine.com
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
Mar 11, 2024 18:00pm

Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform. A study of Edwards’ latest TAVR technology, the SAPIEN 3 Ultra RESILIA valve, found lower rates of paravalvular Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Feb 23, 2024 12:05pm

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:30 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference | EW Stock News
Feb 23, 2024 12:05pm

Edwards Lifesciences Corporation (NYSE: EW) will participate in the TD Cowen Healthcare Conference on March 5, 2024. CEO Bernard Zovighian and CFO Scott Ullem will present at 10:30 a.m. ET. A live webcast will be available on the investor relations website.


Source:Stock Titan